Avdičević, A., Lešnik, S., Bren, U., & Čavka, L. (2026). CDK4/6 Inhibitors for Breast Cancer Therapy—A Review of Clinical Trials, Structural and Computational Approaches. Pharmaceuticals (14248247), 19(4), 610. https://doi.org/10.3390/ph19040610
Chicago Style (17th ed.) CitationAvdičević, Adela, Samo Lešnik, Urban Bren, and Luka Čavka. "CDK4/6 Inhibitors for Breast Cancer Therapy—A Review of Clinical Trials, Structural and Computational Approaches." Pharmaceuticals (14248247) 19, no. 4 (2026): 610. https://doi.org/10.3390/ph19040610.
MLA (9th ed.) CitationAvdičević, Adela, et al. "CDK4/6 Inhibitors for Breast Cancer Therapy—A Review of Clinical Trials, Structural and Computational Approaches." Pharmaceuticals (14248247), vol. 19, no. 4, 2026, p. 610, https://doi.org/10.3390/ph19040610.